Securities registered pursuant to Section 12(b) of the Act:
Title of Class |
| Trading Symbol |
| Name of Exchange on Which Registered |
Common Stock, par value $0.01 per share |
| IRIX |
| Nasdaq Global Market |
|
|
Item 2.02.Results of Operations and Financial Condition.
On March 12, 2020, IRIDEX Corporation issued a press release discussing its financial results for its fourth fiscal quarter and fiscal year 2019, which ended on December 28, 2019. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01.Financial Statements and Exhibits.
|
|
(d) | Exhibits |
|
|
|
Exhibit No. |
| Description |
|
| |
99.1 |
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
| IRIDEX CORPORATION |
|
| |
By: |
| /s/ David I. Bruce |
|
| David I. Bruce President and Chief Executive Officer |
Date: March 12, 2020
-2- |